Longeveron Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Longeveron Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Longeveron Inc - Ordinary Shares - Class A
Rating: 1.26641675
Author: Trendlyne DVM scores

about

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy t...

0.60 -0.02 (-3.23%)

66.67% Fall from 52W High

243.8K

XNAS Volume

XNAS 20 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.2 / 100

Technically Bearish

32.5 / 100

1Yr Price target upside is 1092%

3 analysts

Longeveron Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Longeveron Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy t...

66.67% Fall from 52W High

SWOT Analysis

Longeveron Inc (Class A) Live Price Chart

Longeveron Inc (Class A) Live Price Chart